Advertisement.

PRQR Projected Dividend Yield

Ord/ProQR Therapeutics N.V. ( NASDAQ : PRQR )

ProQR Therapeutics is a clinical stage biopharmaceutical company. Co. is developing a pipeline of RNA therapies for inherited retinal diseases. Beyond its clinical portfolio, Co. has discovered and developed two proprietary RNA editing platform technologies, Axiomer and TRIDENT™. Co.'s editing oligonucleotides are designed to recruit endogenous Adenosine Deaminases Acting on RNA, enzymes to make single nucleotide changes in the RNA in a manner at a desired location. TRIDENT is Co.'s RNA pseudouridylation platform that enables the selective suppression of nonsense mutations that cause human genetic disease.

20 YEAR PERFORMANCE RESULTS

PRQR Dividend History Detail
PRQR Dividend News
PRQR Competitors News

# of Shares: 0

Closing Price: 2.83

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000